Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons.
Level 5 - mechanism / opinion, no new human data
In vitro laboratory experimental study
PubMed 12538700 · doi:10.4049/jimmunol.170.3.1399
What was done
The authors investigated interactions among lipopolysaccharide-binding protein (LBP), chylomicrons, and bacterial endotoxins (LPS and lipoteichoic acid). They tested the kinetics and dose-dependency of LBP-mediated LPS binding to chylomicrons, measured endotoxin toxicity via cytokine secretion in peripheral blood mononuclear cells (PBMC), and compared the LPS-inactivating capacity of postprandial chylomicron levels with low density lipoprotein, very low density lipoprotein, and high density lipoprotein.
What was found
LBP associated with chylomicrons and enhanced the rate and amount of LPS binding in a dose-dependent manner. This interaction prevented endotoxin toxicity as shown by reduced PBMC cytokine secretion. Postprandial concentrations of chylomicrons showed greater LPS-inactivating capacity than LDL, VLDL, or HDL. LBP and chylomicrons also detoxified Gram-positive lipoteichoic acid. The abstract reports directional findings without specific numerical values or statistical metrics.
Why it matters
This study defines a mechanism by which postprandial chylomicrons, facilitated by LBP, bind and neutralize bacterial toxins. It suggests that circulating and intestinal lipoproteins may serve as an endogenous defense against translocated gut-derived endotoxins.
Limits
The study is restricted to in vitro and ex vivo bench experiments without in vivo or clinical validation. The abstract reports no sample sizes (n is unknown), exact numerical concentrations, effect magnitudes, or statistical confidence intervals.
Cited by
- supports All classes of plasma lipoproteins are capable of binding bacterial lipopolysaccharide (endotoxin).